AYTU BIOPHARMA, INC Deferred Tax Assets, Operating Loss Carryforwards
AYTU BIOPHARMA, INC (AYTU) had Deferred Tax Assets, Operating Loss Carryforwards of $103.08 million as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-09-22
- 2026-06-30: Deferred Tax Assets, Operating Loss Carryforwards $103.08M.
- 2025-06-30: Deferred Tax Assets, Operating Loss Carryforwards $119.78M.
- 2024-06-30: Deferred Tax Assets, Operating Loss Carryforwards $119.17M.
- 2023-06-30: Deferred Tax Assets, Operating Loss Carryforwards $113.82M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $114.27M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2026-06-30 | $103.08M 10-K · filed 2026-09-22 | |
| 2025-06-30 | $119.78M 10-K · filed 2026-09-22 | |
| 2024-06-30 | $119.17M 10-K · filed 2025-09-23 | |
| 2023-06-30 | $113.82M 10-K · filed 2024-09-26 | $114.27M 10-K · filed 2023-10-12 |
| 2022-06-30 | $114.44M 10-K · filed 2023-10-12 | |
| 2021-06-30 | $106.71M 10-K · filed 2022-09-27 | |
| 2020-06-30 | $37.19M 10-K · filed 2021-09-28 | |
| 2019-06-30 | $18.09M 10-K · filed 2020-10-06 | |
| 2018-06-30 | $14.46M 10-K · filed 2019-09-26 | |
| 2017-06-30 | $15.44M 10-K · filed 2018-09-06 | |
| 2016-06-30 | $9.20M 10-K · filed 2017-08-31 | |
| 2015-06-30 | $6.34M 10-K · filed 2016-09-01 | |
| 2014-06-30 | $3.85M 10-K · filed 2015-09-28 | |
| 2012-08-31 | $122.70K 10-K · filed 2012-11-29 | |
| 2011-08-31 | $107.80K 10-K · filed 2012-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |